BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36325048)

  • 21. Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure.
    González M; Böer U; Dickel C; Quentin T; Cierny I; Oetjen E; Knepel W
    Diabetologia; 2008 Nov; 51(11):2012-21. PubMed ID: 18762908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.
    Jones HB; Reens J; Brocklehurst SR; Betts CJ; Bickerton S; Bigley AL; Jenkins RP; Whalley NM; Morgan D; Smith DM
    Int J Exp Pathol; 2014 Feb; 95(1):29-48. PubMed ID: 24456331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Transcriptomic Analysis of Zebrafish Glucagon Receptor Mutant Reveals Its Regulated Metabolic Network.
    Kang Q; Hu M; Jia J; Bai X; Liu C; Wu Z; Chen W; Li M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INFLUENCE OF PANCREATIC HORMONES ON ENZYMES CONCERNED WITH UREA SYNTHESIS IN RAT LIVER.
    MCLEAN P; NOVELLO F
    Biochem J; 1965 Feb; 94(2):410-22. PubMed ID: 14348201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent and combined actions of interleukin-1 beta, tumor necrosis factor alpha, and glucagon on amino acid metabolism in the isolated perfused rat liver.
    De Bandt JP; Lim SK; Plassart F; Lucas CC; Rey C; Poupon R; Giboudeau J; Cynober L
    Metabolism; 1994 Jul; 43(7):822-9. PubMed ID: 8028504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin and glucagon regulate pancreatic α-cell proliferation.
    Liu Z; Kim W; Chen Z; Shin YK; Carlson OD; Fiori JL; Xin L; Napora JK; Short R; Odetunde JO; Lao Q; Egan JM
    PLoS One; 2011 Jan; 6(1):e16096. PubMed ID: 21283589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
    Hamberg O
    Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
    Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Liver-α-Cell Axis and Type 2 Diabetes.
    Wewer Albrechtsen NJ; Pedersen J; Galsgaard KD; Winther-Sørensen M; Suppli MP; Janah L; Gromada J; Vilstrup H; Knop FK; Holst JJ
    Endocr Rev; 2019 Oct; 40(5):1353-1366. PubMed ID: 30920583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.
    Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS
    Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-islet glucagon secretion and action in the regulation of glucose homeostasis.
    Wang Q; Liang X; Wang S
    Front Physiol; 2012; 3():485. PubMed ID: 23316165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.
    Mu J; Qureshi SA; Brady EJ; Muise ES; Candelore MR; Jiang G; Li Z; Wu MS; Yang X; Dallas-Yang Q; Miller C; Xiong Y; Langdon RB; Parmee ER; Zhang BB
    PLoS One; 2012; 7(11):e49572. PubMed ID: 23185367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The liver-alpha-cell axis after a mixed meal and during weight loss in type 2 diabetes.
    Otten J; Stomby A; Waling M; Chorell E; Ryberg M; Svensson M; Holst JJ; Olsson T
    Endocr Connect; 2021 Sep; 10(9):1101-1110. PubMed ID: 34382579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis.
    Suppli MP; Bagger JI; Lund A; Demant M; van Hall G; Strandberg C; Kønig MJ; Rigbolt K; Langhoff JL; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2020 Jun; 69(6):1090-1099. PubMed ID: 31974144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
    Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
    Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
    Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
    Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.